Evidence map›Paper›PMID 34183454›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2023

Availability of antidotes in Moroccan hospitals: a national survey.

Rachid Eljaoudi, Youssef Moutaouakkil, Badr Adouani, Yasmina Tadlaoui, Sofia Boukria, Mina Ait El Cadi, Jamal Lamsaouri, Yasser Bousliman

Abstract read
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. An antidote network in Spain, a tool to improve antidote availability in hospitals.European journal of hospital pharmacy : science and practice · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachid EljaoudiPharmacology and Toxicology Department, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco r.eljaoudi@um5s.net.ma.ORCID 0000-0002-0692-2036
Youssef MoutaouakkilPharmacology and Toxicology Department, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.
Badr AdouaniPharmacology and Toxicology Department, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.
Yasmina TadlaouiLaboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.
Sofia BoukriaPharmacology and Toxicology Department, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.
Mina Ait El CadiPharmacology and Toxicology Department, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.
Jamal LamsaouriLaboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.
Yasser BouslimanPharmacology and Toxicology Department, Faculty of Medicine and Pharmacy, Rabat Institute University Mohamed V, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe lack of availability of antidotes is a challenge for hospitals all over the world. The objective of our study was to investigate the availability of antidotes in Moroccan hospitals.

methodsA cross-sectional, questionnaire-based study was conducted from November 2018 to April 2019. The questionnaire was sent to 25 hospitals in order to investigate the availability of 42 selected antidotes based on the International Programme on Chemical Safety list.

resultsThe survey response rate was 68%. Of the 42 selected antidotes, 38 (90.5%) were available depending on the hospitals included in the study. We found a strong correlation between the availability of antidotes and hospital bed capacity, and logistic regression analysis revealed that bed capacity is the only factor strongly associated with higher antidote stock levels. Some essential antidotes such as digoxin-specific antibody, protamine sulfate, flumazenil and glucagon were unavailable in many of the small- and medium-sized hospitals, and methylene blue, sodium nitroprussiate, Prussian blue and anti-snake venom were absent in all of the hospitals.

conclusionDespite the great efforts that have been made to improve the availability of antidotes in Morocco, some of these vital products are still lacking in Moroccan hospitals.

Indexed as

AntidotesHospitalsCross-Sectional StudiesMethylene BlueSurveys and QuestionnairesAntidotesMethylene Blueclinical medicinecritical careemergency medicinehealth care rationingtoxicology

Identifiers

PMID34183454
PMCPMC10176993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.